We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

First-Of-Its-Kind Expandable Cryoballoon Catheter Advances Cryoablation Therapy

By HospiMedica International staff writers
Posted on 10 Aug 2023
Print article
Image: The POLARx FIT cryoablation balloon catheter (Photo courtesy of Boston Scientific)
Image: The POLARx FIT cryoablation balloon catheter (Photo courtesy of Boston Scientific)

Cryoablation, a minimally invasive procedure for atrial fibrillation (AF), involves the use of a balloon catheter to deliver cryotherapy to the pulmonary vein. This action freezes the problematic tissue and forms scar tissue that blocks irregular electrical impulses. Now, a cutting-edge cryoablation system featuring an expandable cryoballoon catheter marks a leap forward in the effective treatment of AF. This system provides physicians the flexibility to customize treatment for each patient, ensuring both safety and efficiency. By combining maneuverability and changing balloon sizes, the system addresses the longstanding challenges posed by varying cardiac anatomies and provides physicians with occlusion capabilities not seen in traditional systems.

Boston Scientific (Marlborough, MA, USA) has secured U.S. Food and Drug Administration (FDA) approval for its POLARx Cryoablation System. This state-of-the-art system, intended for treating patients with paroxysmal AF, incorporates the unique POLARx FIT Cryoablation Balloon Catheter. This innovative device enables two balloon sizes of 28 and 31mm within a single catheter. The system allows physicians to adjust the POLARx FIT catheter to match a patient's specific anatomy during the ablation process, reducing the need for time-consuming and disruptive device changeouts.

In addition, the device allows for the treatment of a wider range of pulmonary vein anatomies and creates lesions at the most effective spots, ensuring that therapy targets the specific heart regions generating disruptive signals that cause AF. A global, prospective, non-randomized, single-arm study has confirmed the safety and efficiency of the POLARx Cryoablation System in treating 385 paroxysmal AF patients. The primary success rate, indicating the absence of any procedure- or device-related complications, stood at an impressive 96.0% at the 12-month mark. Notably, there were no cases of moderate or severe pulmonary vein stenosis, persistent phrenic nerve palsy, or esophageal fistulas. After 12 months, 79.9% of the participants remained free from documented atrial arrhythmias.

"The U.S. approval of the POLARx Cryoablation System, which has been used in more than 25,000 patients worldwide to date, marks an exciting advancement for the treatment of AF and a new era of cryoablation capabilities," said Nick Spadea-Anello, president, Electrophysiology, Boston Scientific. "By prioritizing procedural flexibility and individualized care, this offering transforms a key therapy in the electrophysiology space, addresses the unmet needs of physicians and affirms our commitment to making meaningful innovations to established technologies."

Related Links:
Boston Scientific

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Xenon Light Source
CLV-S400
PACS Workstation
PaxeraView PRO

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more